Wattana Karnpaet Stock

Equities

NEW

TH0575010002

Healthcare Facilities & Services

End-of-day quote Thailand S.E. 06:00:00 2024-06-13 pm EDT 5-day change 1st Jan Change
81.75 THB +2.19% Intraday chart for Wattana Karnpaet +2.19% -25.68%
Sales 2022 523M 14.29M Sales 2023 482M 13.17M Capitalization 1.1B 30.02M
Net income 2022 100M 2.73M Net income 2023 56M 1.53M EV / Sales 2022 2.13 x
Net cash position 2022 67.16M 1.83M Net cash position 2023 103M 2.8M EV / Sales 2023 2.07 x
P/E ratio 2022
11.8 x
P/E ratio 2023
19.6 x
Employees -
Yield 2022
3.39%
Yield 2023
2.09%
Free-Float 3.88%
More Fundamentals * Assessed data
Dynamic Chart
Wattana Karnpaet Public Company Limited Announces Appointment of Ms. Suda Sunsavekul as Chairman of the Audit Committee and Independent Director CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Wattana Karnpaet Public Company Limited Announces Demise of Phoonsakdi Vaisamruat, Chairman of the Audit Committee and Independent Director CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Wattana Karnpaet Public Company Limited Proposes Dividend for the Period 1 January 2023 to 31 December 2023, Payable on the 24 May, 2024 CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Wattana Karnpaet Public Company Limited Proposes Dividend of 2022, Payable on the 18th of May, 2023 CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Wattana Karnpaet Public Company Limited Announces Board Changes CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Wattana Karnpaet Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day+2.19%
1 week+2.19%
Current month+7.57%
1 month-31.88%
3 months-25.68%
6 months-25.68%
Current year-25.68%
More quotes
1 week
76.00
Extreme 76
81.75
1 month
76.00
Extreme 76
110.00
Current year
76.00
Extreme 76
141.50
1 year
76.00
Extreme 76
141.50
3 years
44.00
Extreme 44
210.00
5 years
40.25
Extreme 40.25
210.00
10 years
38.25
Extreme 38.25
210.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 80 84-12-31
Director of Finance/CFO 45 03-12-31
Chief Tech/Sci/R&D Officer 70 85-12-31
Members of the board TitleAgeSince
Chief Executive Officer 80 84-12-31
Chief Tech/Sci/R&D Officer 70 85-12-31
Director/Board Member 78 84-12-31
More insiders
Date Price Change Volume
24-06-14 81.75 +2.19% 200
24-06-13 80 0.00% 201
24-06-07 80 -2.44% 100

End-of-day quote Thailand S.E., June 13, 2024

More quotes
Wattana Karnpaet Public Company Limited is a Thailand-based company that is engaged in hospital and medical trading business. The Company’s business activity is operating hospital under the name North Eastern Wattana Hospital. The Company offers diagnosis and treatment representing a range of medical subspecialty; rehabilitation, dentistry, ophthalmic services, x-rays, child development, pediatrics, neurological surgery, open-heart surgery (CAG+PCI), Orthopedic surgery, general surgery, internal medicine, and emergency care. Its pediatric specialties and services include pediatric specialties and services, general pediatrics, pediatric allergy, pediatric infectious disease, respiratory, and pediatric endocrine. Its urology services include cystoscopy, circumcision, vasectomy, transrectal ultrasound guided prostatic biopsy, extracorporeal shock wave lithotripsy, ureteroscopy lithotripsy, and transurethral resection of prostate.
More about the company